Targeting CD83 for the treatment of graft-versus-host disease

Graft-versus-host disease (GVHD) is a common and often fatal complication of bone marrow transplantation. Antigen-presenting cells from donor and recipient play a critical role in the initiation and maintenance of GVHD. CD83, which is expressed in activated lymphocytes and dendritic cells, is regard...

Descripción completa

Detalles Bibliográficos
Autores principales: WANG, XIONGFEI, WEI, MING Q., LIU, XIAOSONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702702/
https://www.ncbi.nlm.nih.gov/pubmed/23837028
http://dx.doi.org/10.3892/etm.2013.1033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702702/
https://www.ncbi.nlm.nih.gov/pubmed/23837028
http://dx.doi.org/10.3892/etm.2013.1033

Ejemplares similares